comparemela.com

Latest Breaking News On - Sk bioscience co - Page 1 : comparemela.com

SK Bioscience, Vaxxas partner to develop needle-free typhoid vaccine

SK Bioscience Co. Ltd.  and Vaxxas Pty. Ltd. have entered into a joint development agreement that could revolutionize vaccines by developing a vaccine-delivery device combination product using Vaxxas’ high-density microarray patch (HD-MAP) coupled with SK Bioscience’s typhoid vaccine, Skytyphoid.

S Korea Holds Major Job Fair for Foreign Firms, Int l Students

S Korea Holds Major Job Fair for Foreign Firms, Int l Students
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

UPDATE 2-Novavax posts quarterly profit on COVID vaccine sales

Novavax reported a second-quarter profit on Tuesday, helped by strong revenue from its COVID-19 vaccines, but still trimmed its full-year forecast for sales…

S Korea to Designate Biopharma as Nat l Strategic Industry, Double Bio Exports by 2030

S Korea to Designate Biopharma as Nat l Strategic Industry, Double Bio Exports by 2030
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

SK Bioscience Rallies After Clinical Trials of Covid-19 Vaccine Booster

By Kwanwoo Jun SK Bioscience Co Ltd. s shares rallied Thursday after the global phase 3 clinical trials confirmed the efficacy and safety of its Covid-19 vaccine booster. Shares of the. | April 13, 2023

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.